Dec. 24 at 7:31 PM
IQVIA Holdings is entering 2026 with a more constructive and lower-risk outlook, as management expects revenue growth next year to be at least in line with 2025, around 5% reported. Shorter decision cycles and a steadier flow of RFPs point to improving demand visibility, supporting a more predictable environment despite uneven sector growth. The Technology & Analytics Solutions segment is expected to remain resilient, driven by sustained client engagement and continued adoption of analytics and AI tools. Bank of America raised its price target to
$260 and reiterated a Buy rating, citing IQVIA’s strong long-term fundamentals and competitive positioning across Phase I–IV services Strategically IQVIA announced a partnership with Amazon Web Services as its preferred cloud provider to enhance its AI-powered clinical trial and healthcare analytics platform. Additional support came from Stifel, which raised its price target and Morgan Stanley which initiated coverage with an Overweight
$IQV